Related references
Note: Only part of the references are listed.Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: AMulti-InstitutionalStudy
Qing Zhong et al.
ONCOLOGIST (2021)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy
J. X. Lin et al.
BRITISH JOURNAL OF SURGERY (2019)
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
Omer Ben-Aharon et al.
ONCOLOGIST (2019)
Prognosis of Young Survivors of Gastric Cancer in China and the US: Determining Long-Term Outcomes Based on Conditional Survival
Qi-Yue Chen et al.
ONCOLOGIST (2019)
The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging
Haejin In et al.
GASTRIC CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system
Ziyu Li et al.
GASTRIC CANCER (2018)
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Gastric adenocarcinoma
Jaffer A. Ajani et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
On the Restricted Mean Survival Time Curve in Survival Analysis
Lihui Zhao et al.
BIOMETRICS (2016)
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study
Jeung Hui Pyo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer
K. Yamashita et al.
EJSO (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The evaluation of metastatic lymph node ratio staging system in gastric cancer
Yanbing Zhou et al.
GASTRIC CANCER (2013)
Comparison of a Lymph Node Ratio-Based Staging System With the 7th AJCC System for Gastric Cancer Analysis of 18,043 Patients From the SEER Database
Jiping Wang et al.
ANNALS OF SURGERY (2012)
Stage Migration Effect on Survival in Gastric Cancer Surgery With Extended Lymphadenectomy The Reappraisal of Positive Lymph Node Ratio as a Proper N-Staging
Seong-Ho Kong et al.
ANNALS OF SURGERY (2012)
Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery
Karen Becker et al.
ANNALS OF SURGERY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Validity Of Cancer Specific Mortality Within The Surveillence, Epidemiology, And End Results Registry
C. Hu et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Okines et al.
ANNALS OF ONCOLOGY (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
A Novel Subclassification of pT2 Gastric Cancers According to the Depth of Muscularis Propria Invasion Superficial Muscularis Propria Versus Deep Muscularis Propria/Subserosa
Zhe Sun et al.
ANNALS OF SURGERY (2009)
Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes
Da-zhi Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Michael Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy - Results from an Italian multicentric study in 1853 patients
Alberto Marchet et al.
ANNALS OF SURGERY (2007)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The superiority of ratio-based lymph node staging in gastric carcinoma
K Inoue et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
